Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Summit Therapeu ADR (NQ: SMMT )

1.710 +0.040 (+2.40%)
Streaming Delayed Price Updated: 9:53 AM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 117,905
Open 1.700
Bid (Size) 1.710 (26)
Ask (Size) 1.720 (1)
Prev. Close 1.670
Today's Range 1.680 - 1.757
52wk Range 0.6600 - 5.780
Shares Outstanding 97,381,774
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Summit Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
From Schall Law Firm
Via Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Summit Therapeutics Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire

Performance

YTD
-65.80%
-65.80%
1 Month
-24.67%
-24.67%
3 Month
-56.49%
-56.49%
6 Month
+37.90%
+37.90%
1 Year
-50.43%
-50.43%

More News

Read More
Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2022
From Summit Therapeutics Inc.
Via Business Wire
Over $395M Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
Summit Therapeutics Closes Fully-Subscribed $500 Million Rights Offering
From Summit Therapeutics Inc.
Via Business Wire
Macy's, Big Lots, Sprouts Farmers Market And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Workday, AdaptHealth And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Summit Therapeutics’ Rights Offering Nearing Expiration Date
From Summit Therapeutics Inc.
Via Business Wire
Acurx is Setting a High Bar for New Treatments in C. diff
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Ford, Atlassian, Amazon And Other Big Stocks Moving Lower On Friday
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Alphabet And Amazon Are Trading Lower; Here Are 20 Stocks Moving Premarket
Via Benzinga
Summit Therapeutics Announces Timing for Rights Offering for Up to $500 Million
From Summit Therapeutics Inc.
Via Business Wire
Week In Review: HutchMed Announces $1.1 Billion Deal With Takeda For Colorectal Cancer Drug
Via Talk Markets
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Summit Therapeutics Closes Deal with Akeso Inc. to In-License Breakthrough Innovative Bispecific Antibody
From Summit Therapeutics Inc.
Via Business Wire
How Is The Market Feeling About Summit Therapeutics?
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Summit Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Summit Therapeutics Inc.
Via Business Wire
Vera Therapeutics, Phathom Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
Via Benzinga
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In December 2022: Where Do Tesla, Apple, AMC Rank?
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.